Diagnostics investors think positive

Diagnostics companies have had record fundraising on the public markets from 1994-2005. Venture capital also expanded in 2005, raising more than double than in previous years, with $113 million the average quarterly amount raised over the past year compared with only $47 million for a quarter in previous years. Investors seem to be taking seriously expectations that innovations in molecular diagnostics and pharmacogenomics will lead to a rapidly expanding diagnostics market around 2010.